Cree (CREE) Misses Q1 EPS by 2c

Cree (NASDAQ: CREE) reported Q1 EPS of $0.09, $0.02 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $321.3 million versus the consensus estimate of $322.77 million.

GUIDANCE:

Cree sees Q2 2017 EPS of $0.13-$0.19, versus the consensus of $0.15. Cree sees Q2 2017 revenue of $310-330 million, versus the consensus of $336.7 million.

For earnings history and earnings-related data on Cree (CREE) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c